The Sampling Subsidy

The relationship between putting samples in a physician's office closet (often shared by several others in a group practice) and changes in patient treatment behavior has been an elusive metric. Physician distribution of samples to patients can be organized into 1 of 3 major groups: 1. samples...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutical Executive Vol. 25; no. 2; p. 70
Main Authors Lurker, Nancy, Caprara, Bob
Format Trade Publication Article
LanguageEnglish
Published Monmouth Junction MultiMedia Healthcare Inc 01.02.2005
Subjects
Patients
Pharmaceuticals
Reforms
Return on investment
Sales promotions
Samples
United States > US
Online AccessGet full text

Cover

More Information
Summary:The relationship between putting samples in a physician's office closet (often shared by several others in a group practice) and changes in patient treatment behavior has been an elusive metric. Physician distribution of samples to patients can be organized into 1 of 3 major groups: 1. samples given to newly diagnosed patients with a prescription, 2. samples given to previously diagnosed patients with a prescription, and 3. samples given to patients with no prescription. Because the returns associated with sampling are so poorly understood, analyzing the short and long-term effects of changes in the sample distribution system is challenging. Yet one thing is clear: The ROI of the current system is so low that any attempt to change it is worthwhile.
ISSN:0279-6570
2150-735X